Table 1

 Results of microsatellite analysis and immunohistochemistry for patients with truncating mutations in MLH1 or MSH2

PedigreeExonCodon/ amino acid changeNucleotide changeConsequenceCriteriaMSI quotient*MLH1 EXPMSH2 EXPMSH6 EXPReference
*MSI quotient, number of unstable microsatellite markers to the number of markers tested.
†Bethesda positive; ‡Amsterdam I positive; §Amsterdam II positive; ¶Muir Torre. ND, not determined.
EXP, expression of protein in immunohistochemical staining of tumour tissue.
1H1 3R100Xc.298 C>TNonsenseB†4/5++NDSamowitz17
2H1 9c.790+1G>ASplice defectA I‡4/5++Cunningham18
3H1 9c.790+1del GSplice defectA I5/5++Novel
4H1 9c.790+1delGSplice defectA I6/7++Novel
5H1 10295c.884+2T>CSplice defectA II§5/5NDNDNDNovel
6H1 13488c.1463delAFrameshiftA I4/5++Novel
7H1 13497c.1490insCFrameshiftB4/7+NDMöslein 19
8H1 13497c.1490insCFrameshiftA II5/8++Möslein 19
9H1 13497c.1490insCFrameshiftA II5/5NDMöslein 19
10H1 13497c.1490insCFrameshiftB5/7+NDMöslein 19
11H1 15Y561Xc.1683C>GNonsenseB5/5++Novel
12H1 16c.1732-1G>ASplice defectA I4/5++Novel
13H2 4239c.717_721delGGACCinsTTAFrameshiftB7/7+Novel
14H2 6c.1076+1G>ASplice defectB0/0NDNDNDNovel
15H2 7R383Xc.1147C>TNonsenseB0/0NDNDNDBuerstedde20
16H2 7408c.1222insTFrameshiftA I6/7+NDNovel
17H2 7c.1226delAGFrameshiftA II3/5NDNDNDMöslein,19 Liu21
18H2 7c.1226delAGFrameshiftB5/5+Möslein,19 Liu21
19H2 7c.1077- 2A>GSplice defectB8/8+Novel
20H2 8c.1386+1G>ASplice defectMT¶5/7+NDNovel
21H2 8Q429Xc.1285C>TNonsenseA I5/5+NDWijnen 22
22H2 9469c.1408delGFrameshiftB8/8+NDNovel
23H2 9c.1497delAFrameshiftAI5/5+NDNovel
24H2 11c.1720delCFrameshiftB/MT4/5+NDNovel
25H2 12c.2005 + 2T>CSplice defectA I5/5+NDNovel